|
1
|
McGrath J, Saha S, Chant D and Welham J:
Schizophrenia: A concise overview of incidence, prevalence, and
mortality. Epidemiol Rev. 30:67–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Os J and Kapur S: Schizophrenia.
Lancet. 374:635–645. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Long J, Huang G, Liang W, Liang B, Chen Q,
Xie J, Jiang J and Su L: The prevalence of schizophrenia in
mainland China: Evidence from epidemiological surveys. Acta
Psychiatr Scand. 130:244–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mueser KT and McGurk SR: Schizophrenia.
Lancet. 363:2063–2072. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sullivan PF: The genetics of
schizophrenia. PLoS Med. 2:e2122005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O'Donovan MC, Craddock N, Norton N,
Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L,
Georgieva L, et al: Identification of loci associated with
schizophrenia by genome-wide association and follow-up. Nat Genet.
40:1053–1055. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harrison PJ and Owen MJ: Genes for
schizophrenia? Recent findings and their pathophysiological
implications. Lancet. 361:417–419. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stefansson H, Ophoff RA, Steinberg S,
Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors
O, Mortensen PB, et al: Common variants conferring risk of
schizophrenia. Nature. 460:744–747. 2009.PubMed/NCBI
|
|
9
|
Schizophrenia Working Group of the
Psychiatric Genomics Consortium, . Biological insights from 108
schizophrenia-associated genetic loci. Nature. 511:421–427. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Farrell MS, Werge T, Sklar P, Owen MJ,
Ophoff RA, O'Donovan MC, Corvin A, Cichon S and Sullivan PF:
Evaluating historical candidate genes for schizophrenia. Mol
Psychiatry. 20:555–562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rubio MD, Haroutunian V and
Meador-Woodruff JH: Abnormalities of the Duo/Ras-related C3
botulinum toxin substrate 1/p21-activated kinase 1 pathway drive
myosin light chain phosphorylation in frontal cortex in
schizophrenia. Biol Psychiatry. 71:906–914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen SY, Huang PH and Cheng HJ:
Disrupted-in-Schizophrenia 1-mediated axon guidance involves
TRIO-RAC-PAK small GTPase pathway signaling. Proc Natl Acad Sci
USA. 108:5861–5866. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Datta D, Arion D, Corradi JP and Lewis DA:
Altered expression of CDC42 signaling pathway components in
cortical layer 3 pyramidal cells in schizophrenia. Biol Psychiatry.
78:775–785. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu J and Clark AG: Impact of microRNA
regulation on variation in human gene expression. Genome Res.
22:1243–1254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Caputo V, Sinibaldi L, Fiorentino A,
Parisi C, Catalanotto C, Pasini A, Cogoni C and Pizzuti A: Brain
derived neurotrophic factor (BDNF) expression is regulated by
microRNAs miR-26a and miR-26b allele-specific binding. PLoS One.
6:e286562011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi S, Leites C, He D, Schwartz D, Moy W,
Shi J and Duan J: MicroRNA-9 and microRNA-326 regulate human
dopamine D2 receptor expression, and the microRNA-mediated
expression regulation is altered by a genetic variant. J Biol Chem.
289:13434–13444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rossi M, Kilpinen H, Muona M, Surakka I,
Ingle C, Lahtinen J, Hennah W, Ripatti S and Hovatta I:
Allele-specific regulation of DISC1 expression by miR-135b-5p. Eur
J Hum Genet. 22:840–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lavi-Itzkovitz A, Peterman N, Jost D and
Levine E: Quantitative effect of target translation on small RNA
efficacy reveals a novel mode of interaction. Nucleic Acids Res.
42:12200–12211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim Y, Xia K, Tao R, Giusti-Rodriguez P,
Vladimirov V, van den Oord E and Sullivan PF: A meta-analysis of
gene expression quantitative trait loci in brain. Transl
Psychiatry. 4:e4592014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
China Bureau of Statistics, . China
statistical yearbookPopulation. China Statistics press; Nanning:
2014
|
|
21
|
Su L, Long J, Liang B, Gu L, Pan R, Li L,
Zhou Y, Tang X, Jiang J, Chen Q, et al: Association between the
NOTCH4 gene rs3131296 polymorphism with schizophrenia risk in the
Chinese Zhuang population and Chinese Han population. Acta
Neuropsychiatr. 26:240–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su L, Long J, Pan R, Xie X, Mao X, Zhou Y,
Chen Q and Wei B: Influence of NRGN rs12807809 polymorphism on
symptom severity in individuals with schizophrenia in the Han
population but not the Zhuang population of south China. Acta
Neuropsychiatr. 27:221–227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kay SR, Fiszbein A and Opler LA: The
positive and negative syndrome scale (PANSS) for schizophrenia.
Schizophr Bull. 13:261–276. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Allen F, Avram HM, Ruth R and Michael BF:
The DSM-IV Classification and PsychopharmacologyThe Fourth
Generation of Progress. Raven Press; New York, NY: 1995
|
|
25
|
Zheng M, Liu J, Zhu M, Yin R, Dai J, Sun
J, Shen W, Ji Y, Jin G, Ma H, et al: Potentially functional
polymorphisms in PAK1 are associated with risk of lung cancer in a
Chinese population. Cancer Med. 4:1781–1787. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Konopaske GT, Lange N, Coyle JT and Benes
FM: Prefrontal cortical dendritic spine pathology in schizophrenia
and bipolar disorder. JAMA Psychiatry. 71:1323–1331. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Edwards DC, Sanders LC, Bokoch GM and Gill
GN: Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase
signalling to actin cytoskeletal dynamics. Nat Cell Biol.
1:253–259. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hayashi K, Ohshima T, Hashimoto M and
Mikoshiba K: Pak1 regulates dendritic branching and spine
formation. Dev Neurobiol. 67:655–669. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang W, Zhou Z, Asrar S, Henkelman M, Xie
W and Jia Z: p21-Activated kinases 1 and 3 control brain size
through coordinating neuronal complexity and synaptic properties.
Mol Cell Biol. 31:388–403. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Conne B, Stutz A and Vassalli JD: The 3′
untranslated region of messenger RNA: A molecular ‘hotspot’ for
pathology? Nat Med. 6:637–641. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Campbell DB, Ebert PJ, Skelly T, Stroup
TS, Lieberman J, Levitt P and Sullivan PF: Ethnic stratification of
the association of RGS4 variants with antipsychotic treatment
response in schizophrenia. Biol Psychiatry. 63:32–41. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong Y, Wu CN, Xu J, Feng G, Xing QH, Fu
W, Li C, He L and Zhao XZ: Polymorphisms in microRNA target sites
influence susceptibility to schizophrenia by altering the binding
of miRNAs to their targets. Eur Neuropsychopharmacol. 23:1182–1189.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saetre P, Agartz I, De Franciscis A,
Lundmark P, Djurovic S, Kähler A, Andreassen OA, Jakobsen KD,
Rasmussen HB, Werge T, et al: Association between a
disrupted-in-schizophrenia1 (DISC1) single nucleotide polymorphism
and schizophrenia in a combined Scandinavian case-control sample.
Schizophr Res. 106:237–241. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nadalin S, Giacometti J and
Buretić-Tomljanović A: PPARα-L162V polymorphism is not associated
with schizophrenia risk in a Croatian population. Prostaglandins
Leukot Essent Fatty Acids. 91:221–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang S, Li W, Zhang H, Wang X, Yang G,
Zhao J, Yang Y and Lv L: Association of microRNA137 gene
polymorphisms with age at onset and positive symptoms of
schizophrenia in a Han Chinese population. Int J Psychiatry Med.
47:153–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Andreasen NC and Carpenter WT Jr:
Diagnosis and classification of schizophrenia. Schizophr Bull.
19:199–214. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rietkerk T, Boks MP, Sommer IE, Liddle PF,
Ophoff RA and Kahn RS: The genetics of symptom dimensions of
schizophrenia: Review and meta-analysis. Schizophr Res.
102:197–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Boks MP, Leask S, Vermunt JK and Kahn RS:
The structure of psychosis revisited: The role of mood symptoms.
Schizophr Res. 93:178–185. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Labbe A, Bureau A, Moreau I, Roy MA,
Chagnon Y, Maziade M and Merette C: Symptom dimensions as
alternative phenotypes to address genetic heterogeneity in
schizophrenia and bipolar disorder. Eur J Hum Genet. 20:1182–1188.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
World Health Organization, . The ICD-10
classification of mental and behavioural disorders: Clinical
descriptions and diagnostic guidelines. Geneva: World Health
Organization. 1993.
|
|
41
|
Ioannidis JP, Ntzani EE and Trikalinos TA:
‘Racial’ differences in genetic effects for complex diseases. Nat
Genet. 36:1312–1318. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yin R, Chen Y, Pan S, He F, Liu T, Yang D,
Wu J, Yao L, Lin W, Li R and Huang J: Comparison of lipid levels,
hyperlipidemia prevalence and its risk factors between Guangxi Hei
Yi Zhuang and Han populations. Arch Med Res. 37:787–793. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ruixing Y, Hui L, Jinzhen W, Weixiong L,
Dezhai Y, Shangling P, Jiandong H and Xiuyan L: Association of diet
and lifestyle with blood pressure in the Guangxi Hei Yi Zhuang and
Han populations. Public Health Nutr. 12:553–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yin R, Li H, Wu J, Lin W, Yang D, Pan S,
Huang J and Long X: Effects of alcohol consumption and other
lifestyle behaviors on blood pressure for the middle-aged and
elderly in the Guangxi Hei Yi Zhuang and Han populations. Alcohol.
41:541–550. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yin R, Wang Y, Chen G, Lin W, Yang D and
Pan S: Lipoprotein lipase gene polymorphism at the PvuII locus and
serum lipid levels in Guangxi Hei Yi Zhuang and Han populations.
Clin Chem Lab Med. 44:1416–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu J, Yin R, Lin W, Pan S and Yang D:
Hepatic lipase gene −514C/T polymorphism in the Guangxi Hei Yi
Zhuang and Han populations. Lipids. 43:733–740. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yaju D, Ruixing Y, Yiyang L, Yijiang Z,
Weixiong L, Shangling P and Dezhai Y: Polymorphism of the sterol
regulatory element-binding protein-2 gene and its association with
serum lipid levels in the Guangxi Hei Yi Zhuang and Han
populations. Am J Med Sci. 337:14–22. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Blomström A, Karlsson H, Wicks S, Yang S,
Yolken RH and Dalman C: Maternal antibodies to infectious agents
and risk for non-affective psychoses in the offspring-a matched
case-control study. Schizophr Res. 140:25–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Veling W, Susser E, Selten JP and Hoek HW:
Social disorganization of neighborhoods and incidence of psychotic
disorders: A 7-year first-contact incidence study. Psychol Med.
45:1789–1798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Markham JA and Koenig JI: Prenatal stress:
Role in psychotic and depressive diseases. Psychopharmacology
(Berl). 214:89–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
